Hurler Syndrome Global Clinical Trials Review 2015

1
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome)
Global Clinical Trials Review, H1, 2015 By Life
Science Industry Research

• Browse more reports on Pharmaceuticals at
  http//www.lifescienceindustryresearch.com/categor
  y/pharmaceuticals .

http//www.lifescienceindustryresearch.com/
sales_at_lifescienceindustryresearch.com 1 888
391 5441
2
Mucopolysaccharidosis I (MPS I) (Hurler
Syndrome) Global Clinical Trials Review, H1, 2015

• Report includes an overview of the trial numbers
  and their recruitment status as per the site of
  trial conduction across the globe. The databook
  offers a preliminary coverage of disease clinical
  trials by their phase, trial status, prominence
  of the sponsors and also provides briefing
  pertaining to the number of trials for the key
  drugs for treating Mucopolysaccharidosis I (MPS
  I) (Hurler Syndrome). This report is built using
  data and information sourced from proprietary
  databases, primary and secondary research and
  in-house analysis by GlobalDatas team of
  industry experts.
• Complete report available at http//www.lifescienc
  eindustryresearch.com/mucopolysaccharidosis-i-mps-
  i-hurler-syndrome-global-clinical-trials-review-h1
  -2015.html .

http//www.lifescienceindustryresearch.com/
sales_at_lifescienceindustryresearch.com 1 888
391 5441
3
Mucopolysaccharidosis I (MPS I) (Hurler
Syndrome) Global Clinical Trials Review, H1, 2015

• Table of Content-
• Table of Contents 2.
• List of Tables 4.
• List of Figures 5.
• Introduction 6.
• Mucopolysaccharidosis I (MPS I) (Hurler Syndrome)
  6.
• Report Guidance 6.
• Clinical Trials by Region 7.
• Clinical Trials and Average Enrollment by Country
  8.

http//www.lifescienceindustryresearch.com/
sales_at_lifescienceindustryresearch.com 1 888
391 5441
4
Mucopolysaccharidosis I (MPS I) (Hurler
Syndrome) Global Clinical Trials Review, H1, 2015

• Scope-
• Data on the number of clinical trials conducted
  in North America, South and Central America,
  Europe, Middle-East and Africa and Asia-pacific
  and top five national contributions in each.
• Clinical trial (complete and in progress) data by
  phase, trial status, subjects recruited and
  sponsor type.
• Listings of discontinued trials (suspended,
  withdrawn and terminated).

http//www.lifescienceindustryresearch.com/
sales_at_lifescienceindustryresearch.com 1 888
391 5441
5
Mucopolysaccharidosis I (MPS I) (Hurler
Syndrome) Global Clinical Trials Review, H1, 2015

• Reasons to Buy
• Understand the dynamics of a particular
  indication in a condensed manner.
• Abridged view of the performance of the trials in
  terms of their status, recruitment, location,
  sponsor type and many more.
• Obtain discontinued trial listing for trials
  across the globe.
• Espy the commercial landscape of the major
  Universities / Institutes / Hospitals or
  Companies.

http//www.lifescienceindustryresearch.com/
sales_at_lifescienceindustryresearch.com 1 888
391 5441
6
Mucopolysaccharidosis I (MPS I) (Hurler
Syndrome) Global Clinical Trials Review, H1, 2015

• For more details contact Mr. Ritesh Tiwari
  sales_at_lifescienceindustryresearch.com /
  18883915441

Life Science Industry Research lifescienceindustry
research.com, an online repository of market 
research reports, offers in-depth analysis of
over 5000 market segments. Life Science Industry
Research library has syndicated reports by
leading market research  publishers across the
globe.

http//www.lifescienceindustryresearch.com/
sales_at_lifescienceindustryresearch.com 1 888
391 5441